| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/28/2010 | WO2010011679A2 Improved protein production in a host |
| 01/28/2010 | WO2010010848A1 Method for production of antibody in cultured mammalian cell by using molecular chaperone |
| 01/28/2010 | WO2010010674A1 FUCOSE α1→6-SPECIFIC LECTIN |
| 01/28/2010 | WO2010010178A1 The tuberculosis rv2707c protein, compositions and uses thereof |
| 01/28/2010 | WO2009151491A9 In vivo incorporation of an unnatural amino acid comprising a 1,2-aminothiol group |
| 01/28/2010 | WO2009148628A9 Tyrosine phosphorylation sites in tnk1 kinase |
| 01/28/2010 | WO2009140623A3 Anti-psgl-1 antibodies and methods of identification and use |
| 01/28/2010 | WO2009042165A3 Mutant botulinum neurotoxin serotype a polypeptide and uses thereof |
| 01/28/2010 | WO2003061603A9 Global suppressors of p53 mutations |
| 01/28/2010 | US20100024050 Pufa polyketide synthase systems and uses thereof |
| 01/28/2010 | US20100024047 Prion-free transgenic ungulates |
| 01/28/2010 | US20100022751 Recombinant toxin fragments |
| 01/28/2010 | US20100022452 Nanobodies for the treatment of aggregation-mediated disorders |
| 01/28/2010 | US20100021995 Biological products |
| 01/28/2010 | US20100021991 Methods for Producing Modified Glycoproteins |
| 01/28/2010 | US20100021987 Compositions, Methods, and Kits for Enhancing Protein Expression |
| 01/28/2010 | US20100021968 Novel chlorella species and uses therefor |
| 01/28/2010 | US20100021967 Alpha Factor Signal Peptide For Producing a Polypeptide |
| 01/28/2010 | US20100021965 Protein Expression in Rodent Cells |
| 01/28/2010 | US20100021964 Microorganism for producing recombinant pig liver esterase |
| 01/28/2010 | US20100021963 Genetic incorporation of unnatural amino acids into proteins in mammalian cells |
| 01/28/2010 | US20100021911 Production host cell lines |
| 01/28/2010 | US20100021612 Method for the production of fusion proteins in transgenic mammal milk |
| 01/28/2010 | US20100021492 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 01/28/2010 | US20100021490 Preparation of soluble N-protein/truncated P-protein complexes or N-proteinssoluble in a virus of the paramyxoviridae family and use thereof in vaccines |
| 01/28/2010 | US20100021486 Tslp vaccine for the treatment of th2 mediated inflammatory conditions |
| 01/28/2010 | US20100021474 Methods and compositions for targeting hepsin |
| 01/28/2010 | US20100021473 Bispecific Ligands With Binding Specificity to Cell Surface Targets and Methods of Use Therefor |
| 01/28/2010 | US20100021470 Monoclonal antibody production by ebv transformation of b cells |
| 01/28/2010 | US20100021468 Novel mhc class ii restricted t cell epitopes from the cancer anitgen, ny eso-1 |
| 01/28/2010 | US20100021467 Method of detecting a cancer cell by aberrant expression of a human k+ ion channel |
| 01/28/2010 | US20100021466 Antagonistic Human LIGHT-Specific Human Monoclonal Antibodies |
| 01/28/2010 | US20100021452 Compositions and methods of use for therapeutic antibodies |
| 01/27/2010 | EP2147104A1 Use of an aspartic protease (nsp24) signal sequence for heterologous protein expression |
| 01/27/2010 | EP2147098A1 Use of protein hydrolysates to stabilize metalloprotease detergent formulations |
| 01/27/2010 | EP2147093A1 Process for obtaining bioactive recombinant protein from inclusion bodies |
| 01/27/2010 | EP2146745A2 Novel compounds |
| 01/27/2010 | EP2146589A2 Whey protein hydrolysate |
| 01/27/2010 | EP1751299B1 Methods for evaluating ribonucleotide sequences |
| 01/27/2010 | EP1704227B1 Immortalized hepatocytes |
| 01/27/2010 | EP1527188B1 Process for the production of increased amounts of correctly folded heterologous protein in inclusion bodies |
| 01/27/2010 | EP1362106B1 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 01/27/2010 | CN101636502A Human antibodies that bind CD19 and uses thereof |
| 01/27/2010 | CN101633947A New method for preparing sunflower seed meal proteolytic peptide and application of sunflower seed meal proteolytic peptide |
| 01/27/2010 | CN101633946A ELP fusion protein and application thereof |
| 01/27/2010 | CN101633945A Method for preparing globin peptide powder containing VVYP peptide |
| 01/27/2010 | CN101633944A Application of trichosporon behrend for producing glutathione |
| 01/27/2010 | CN101633692A Methods for making apo-2 ligand using divalent metal ions |
| 01/27/2010 | CN100584948C Procine circoviruses, vaccines and diagnostic reagents |
| 01/27/2010 | CN100584946C Method of humanizing immune system molecules |
| 01/27/2010 | CN100584945C Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 01/27/2010 | CN100584857C Process of high purity albumin production |
| 01/27/2010 | CN100584343C Medicine health-care usage of globefish I collagen extraction and preparing process thereof |
| 01/26/2010 | US7651857 Inhibiting antigen presentation, comprising the step of supplying to an antigen-presenting cell, such as a dendritic cell, or precursor cell, a modulator, preferably an enhancer, of Toll-related receptor signalling |
| 01/26/2010 | US7651854 Administering PC cell-derived growth factor (PCDGF); improves the efficiency of primary hematopoietic cell culture |
| 01/26/2010 | US7651849 Increased activity and stability at increased pH and temperature |
| 01/26/2010 | US7651848 Mixing a protein solution with a refolding buffer at mixing conditions; obtaining a biologically active recombinant protein by reconstituting the protein from a denatured state to its active form |
| 01/26/2010 | US7651688 Method of modulating the activity of functional immune molecules to CD52 |
| 01/26/2010 | US7651582 Wood adhesives containing solid residues of biomass fermentations |
| 01/26/2010 | CA2421588C Tnf receptor-like molecules and uses thereof |
| 01/26/2010 | CA2419490C Functional protein arrays |
| 01/26/2010 | CA2328803C Anti-procalcitonin antibodies and the preparation and use thereof |
| 01/21/2010 | WO2010009350A2 Compositions and methods for modulating nod-like receptor activity and uses thereof |
| 01/21/2010 | WO2010008764A1 Pseudomonas fluorescens strains for production of extracellular recombinant protein |
| 01/21/2010 | WO2010008075A1 Anti-system asc amino acid transporter 2 (asct2) antibody |
| 01/21/2010 | WO2010008051A1 Anti-human clcp1 antibody and use thereof |
| 01/21/2010 | WO2010007246A1 Self-replicating vector lacking an antibiotic-resistance gene |
| 01/21/2010 | WO2009134027A3 Anti-nucleic acid antibody inducing cell death of cancer cells and composition for preventing or treating cancers comprising the same |
| 01/21/2010 | WO2009102493A3 Use of egfrviii to identify and target cancer stem cells |
| 01/21/2010 | WO2004041170A9 Compositions and methods for the treatment of immune related diseases |
| 01/21/2010 | WO2004024097A9 Compositions and methods for the treatment of immune related diseases |
| 01/21/2010 | WO2003061561A9 Epsilon immunoglobulin chain derived peptides for induction of anti-ige antibodies |
| 01/21/2010 | WO2003006609A9 Human cytokine receptor |
| 01/21/2010 | WO2002078642A9 Differentially-expressed and up-regulated polynucleotides and polypeptides in breast cancer |
| 01/21/2010 | US20100016561 N-Acetylglucosaminyltransferase III Expression in Lower Eukaryotes |
| 01/21/2010 | US20100016557 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 01/21/2010 | US20100016556 Method for making humanized antibodies |
| 01/21/2010 | US20100016555 N-Acetylglucosaminyltransferase III Expression in Lower Eukaryotes |
| 01/21/2010 | US20100016431 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition |
| 01/21/2010 | US20100016234 Signal peptides, nucleic acid molecules and methods for treatment of caries |
| 01/21/2010 | US20100016228 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 01/21/2010 | US20100015698 Human Chondroitinase Glycoprotein (CHASEGP), Process for Preparing the Same, and Pharmaceutical Compositions Comprising Thereof |
| 01/21/2010 | US20100015665 Antibodies and diagnostics |
| 01/21/2010 | US20100015664 Protease, dna encoding the same, and method for manufacturing protease |
| 01/21/2010 | US20100015663 Method for producing an antifungal peptide in a filamentous fungal host cell |
| 01/21/2010 | US20100015662 Use of cellobiohydrolase from phanerochaete |
| 01/21/2010 | US20100015661 Antibody-rnase-conjugate |
| 01/21/2010 | US20100015660 Production of Recombiant Products Using Capillary Membranes |
| 01/21/2010 | US20100015659 PC5 as a Factor IX Propeptide Processing Enzyme |
| 01/21/2010 | US20100015640 Nucleic Acid, Polypeptide and Its Use |
| 01/21/2010 | US20100015593 Method for producing a composition for promoting survival of transplanted hematopoietic stem cell |
| 01/21/2010 | US20100015170 Flagellin mutant vaccine |
| 01/21/2010 | US20100015153 Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells and Antibodies That Identify the Same |
| 01/21/2010 | US20100015150 Tdf-related compounds and analogs thereof |
| 01/21/2010 | US20100015135 Anti-ephb4 antibodies and methods using same |
| 01/21/2010 | US20100015133 Methods for Producing Polypeptides by Regulating Polypeptide Association |
| 01/21/2010 | US20100015131 Composition Comprising Antibodies to LINGO or Fragments Thereof |
| 01/21/2010 | US20100015123 Novel thrombolytic molecules and a process therefor |
| 01/21/2010 | US20100015122 Cloning of honey bee allergen |
| 01/21/2010 | US20100015120 Hybrid protein that converts arachidonic acid into prostacyclin |